Nasal Aβ treatment induces anti-Aβ antibody production and decreases cerebral amyloid burden in PD-APP mice

Annals of the New York Academy of Sciences

Volumn 920, Issue , 2000, Pages 328-331

  Lemere, C A ^a,c   Maron, R ^b   Spooner, E T ^a   Grenfell, T J ^b   Mori, C ^a   Desai, R ^a   Hancock, W W ^b   Weiner, H L ^b   Selkoe, D J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN 1-40; AMYLOID PRECURSOR PROTEIN; MYELIN BASIC PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0034530636     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06943.x     Document Type: Conference Paper

References (19)

1. Translating cell biology into therapeutic advances in Alzheimer's disease
2. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
3. Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
4. Complement activation by β-amyloid in Alzheimer disease
5. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease
6. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
7. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and neurofibrillary pathology of Alzheimer's disease and other degenerative disorders
8. Molecular mechanisms of fibrillogenesis and the protective role of amyloid P component: Two possible avenues for therapy
9. The pathogenesis of senile plaques
10. Regulatory T-cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
11. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein
12. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments
13. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity
14. Suppression of experimental autoimmune myasthenia gravis by nasal adminsitration of acetylcholine receptor
15. Oral adminstration of acetylcholine receptor: Effects on experimental myasthenia gravis
16. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
17. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease
18. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease
19. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse